Further evidence for direct pro-resorptive actions of FSH

Biochemical and Biophysical Research Communications

Volumn 394, Issue 1, 2010, Pages 6-11

  Sun, Li ^a   Zhang, Zhiyuan ^a   Zhu, Ling Ling ^a   Peng, Yuanzhen ^a   Liu, Xuan ^a   Li, Jianhua ^a   Agrawal, Manasi ^a   Robinson, Lisa J ^b   Iqbal, Jameel ^a   Blair, Harry C ^b   Zaidi, Mone ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone loss; FSH; Gonadotropin; Osteoclast; Osteoporosis

Indexed keywords

ESTROGEN; FOLLITROPIN; FOLLITROPIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SURVIVAL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ANIMALS; BONE RESORPTION; CELL LINE; FOLLICLE STIMULATING HORMONE; HUMANS; MICE; OSTEOCLASTS; RECEPTORS, FSH;

MURINAE;

EID: 77949872925     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.113     Document Type: Article

References (26)

1. Albright F., Smith P.H., and Richardson A.M. Post menopausal osteoporosis. JAMA 1167 (1941) 2465-2474
2. Sun L., Peng Y., Sharrow A.C., et al. FSH directly regulates bone mass. Cell 125 (2006) 247-260
3. Gao J., Tiwari-Pandey R., Samadfam R., et al. Altered ovarian function affects skeletal homeostasis independent of the action of follicle stimulating hormone. Endocrinology 148 (2007) 2613-2621
4. Sowers M.R., Jannausch M., McConnell D., et al. Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metabol. 91 (2006) 1261-1267
5. Devleta B., Adem B., and Seneda S. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J. Bone Miner. Res. 22 (2004) 360-364
6. Iqbal J., Sun L., Kumar T.R., et al. Follicle stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. 103 (2006) 14925-14930
7. Wu Y., Torcheria J., Yao W., et al. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen deficiency. PLoS One 2 (2007) e586
8. Nicks K.M., Akel N.S., Suva L.J., and Gaddy D. Inhibin directly targets suppression of isolated human osteoclast precursor development and activity. J. Bone Miner. Res. 23 (2008) S150
9. Wu X.Y., Wu X.P., Xie H., et al. Age-related chanhes in biochemical markers of bone turnover and gonadotropins levels and their relationship among Chinese adult women. Osteoporos. Int. 21 (2010) 275-285
10. Cannon J.G., Cortez-Cooper M., Meaders E., et al. Follicle stimulating hormone, interleukin-1 and bone density in adult women. Am. J. Physiol. (2009) (E-pub. Dec 8)
11. Recker R., Lappe J., Davies K.M., and Heaney R. Bone remodeling increases substantially in the years after menopause, remains increased in older osteoporosis patients. J. Bone Miner. Res. 19 (2004) 1628-1633
12. Akhter M.P., Lappe J.M., Davies K.M., and Recker R.R. Transmenopausal changes in the trabecular bone structure. Bone 41 (2007) 111-116
13. Randolph J.F., Sowers M., Bondarenko I.V., et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metabol. 89 (2004) 1555-1561
14. Sowers M.R., Greendale G.A., Bondarenko J., et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos. Int. 14 (2003) 191-197
15. Xu Z.R., Wang A.H., Wu X.P., et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin. Chim. Acta 400 (2009) 8-13
16. D. Rendina, F. Gianfrancesco, G. Di Fillipino, et al., FSHR gene polymorphisms influence bone mineral density and bone turnover in post-menopausal women, Eur. J. Endocrinol., in press.
17. Robinson L.J., Tourkova I., Wang Y., et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem. Biophys. Res. Commun. 394 (2010) 12-17
18. Pacifici R. Estrogen, cytokines and pathogenesis of post-menopausal osteoporosis. J. Bone Miner. Res. 11 (1996) 1043-1051
19. Hase H., Ando T., Eldeiry L., et al. TNFalpha mediates the skeletal effects of thyroid-stimulating hormone. Proc. Natl. Acad. Sci. 103 (2006) 12849-12854
20. Abe E., Marians R.C., Yu W., et al. TSH is a negative regulator of skeletal remodeling. Cell 115 (2003) 151-162
21. Sun L., Vukicevic S., Baliram R., et al. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc. Natl. Acad. Sci. 105 (2008) 4289-4294
22. Pazianas M., Rhim A.D., Weinberg A.M., et al. The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease. Ann. NY Acad. Sci. 1068 (2006) 543-556
23. Liu S., Cheng Y., Fan M., et al. FSH aggravates periodontitis-related bone loss in ovariectomized rats. J. Dent. Res. (2010) (E-pub. February 5)
24. R. Pacifici, Immune system, FSH and regulation of bone mass, in: Proceedings of the First Annual Meeting of the Società Italiana dell'Osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro, Torino, Clinical Cases in Mineral and Bone Metabolism 6 (2009) S32. Available at: .
25. 2+ homeostasis. Nat. Cell Biol. 7 (1999) 409-414
26. Yaroslavskiy B.B., Li Y., Ferguson D.J., et al. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J. Cell Biochem. 91 (2004) 962-972